Referências bibliográficas

Home » Profissionais de Saúde » Referências bibliográficas

referencias-01

  • 1. Burns KC, Boudreau C, Panepinto JA. Attitudes regarding fertility preservation in female adolescent cancer patients. J Pediatr Hematol Oncol. 2006; 28(6):350-354.
  • 2. Schover LR, Rybicki LA, Martin BA, Bringelsen KA. Having children after cancer: a pilot survey of survivors’ attitudes and experiences. Cancer. 1999; 86(4):697-709.
  • 3. Woodruff TK. The Oncofertility Consortium—addressing fertility in young people with cancer. Nat Rev Clin Oncol. 2010 August; 7(8): 466–475.
  • 4. Su HI, Sammel MD, Velders L, Horn M, Stankiewicz C, Matro J, Gracia CR, Green J, DeMichele A. Association of cyclophosphamide drug-metabolizing enzyme polymorphisms and chemotherapy-related ovarian failure in breast cancer survivors. Fertil Steril. 2010 Jul;94(2):645-54.
  • 5. van Casteren NJ, Boellaard WP, Romijn JC, Dohle GR. Gonadal dysfunction in male cancer patients before cytotoxic treatment. Int J Androl. 2010; 33:73–9.
  • 6. Knopman JM, Papadopoulos EB, Grifo JA, Fino ME, Noyes N. Surviving childhood and reproductive-age malignancy: effects on fertility and future parenthood. Lancet Oncol 2010; 11: 490–98.
  • 7. Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, Quinn G, Wallace WH, Oktay K; American Society of Clinical Oncology. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013 Jul 1; 31(19):2500-10.
  • 8.Peccatori FA, Azim HA Jr, Orecchia R, Hoekstra HJ, Pavlidis N, Kesic V, Pentheroudakis G; ESMO Guidelines Working Group. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013 Oct; 24 Suppl 6:vi160-70.
  • 9.The Practice Committee of the American Society for Reproductive Medicine. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2013 Nov;100(5):1214-23.
  • 10.Selk A, Belej-Rak T, Shapiro H, Greenblatt E. Use of an oncology sperm bank: a Canadian experience. Can Urol Assoc J. 2009 Jun; 3(3):219-222.
  • 11. van Casteren NJ, van Santbrink EJ, van Inzen W, Romijn JC, Dohle GR. Use rate and assisted reproduction technologies outcome of cryopreserved semen from 629 cancer patients. Fertil Steril. 2008 Dec; 90(6):2245-50. doi: 10.1016/j.fertnstert.2007.10.055. Epub 2008 Jan 14.
  • 12.Dohle GR. Male infertility in cancer patients: Review of the literature. Int J Urol. 2010 Apr; 17(4):327-31.
  • 13. Fertile Hope 2013. Pregnancy & Children After Cancer. Consultado em 04/12/2013. Acessível em http://www.fertilehope.org/learn-more/cancer-and-fertility-info/pregnancy-and-children-after-cancer.cfm
  • 14. Ulug U, Bener F, Karagenc L, Ciray N, Bahceci M. Outcomes in couples undergoing ICSI: comparison between fresh and frozen thawed surgically retrieved spermatozoa. Int J Androl. 2005; 28(6):343–9.
  • 15. Kalsi J, Thum MY, Muneer A, Pryor J, Abdullah H, Minhas S. Analysis of the outcome of intracytoplasmic sperm injection using fresh or frozen sperm. BJU Int. 2011 Apr;107(7):1124-8.
  • 16. Urology Care Foundation. Sperm retrieval. Consultado em 04/12/2013. Acessível em http://www.urologyhealth.org/urology/index.cfm?article=133. Last update in April 2013.
  • 17. Nayak SR, Wakim AN. Random-start gonadotropin-releasing hormone (GnRH) antagonist-treated cycles with GnRH agonist trigger for fertility preservation. Fertil Steril. 2011 Jul; 96(1):e51-4.
  • 18. von Wolff M, Thaler CJ, Frambach T, Zeeb C, Lawrenz B, Popovici RM, Strowitzki T. Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril 2009; 92: 1360-1365.
  • 19. Westphal LM, Massie JAM. Oncofertility Medical Practice: Clinical Issues and Implementation; Chapter 4: Embryo and Oocyte Banking. C. Gracia and T.K. Woodruff (eds.). Springer 2012. Acessível em http://oncofertility.northwestern.edu/sites/default/files/uploadedfilecontent/embryo_and_oocyte_banking_-_lynn_m._westphal_and_jamie_a.m._massie.pdf
  • 20. De Sutter P, Gerris J, Dhont M. Assisted reproductive technologies: how to minimize the risks and complications in developing countries? ESHRE Monogr (2008) 2008 (1): 73-76.
  • 21. Rodriguez-Wallberg KA, Oktay K. Fertility Preservation and Pregnancy in Women With and Without BRCA Mutation–Positive Breast Cancer. The Oncologist 2012; 17: 1409–1417
  • 22. Siristatidis C, Sergentanis TN, Kanavidis P, Trivella M, Sotiraki M, Mavromatis I, Psaltopoulou T, Skalkidou A,Petridou ET. Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer—a systematic review and meta-analysis. Hum Reprod Update 2013; Vol.19, No.2 pp. 105–123.
  • 23. Wennerholm UB, Söderström-Anttila V, Bergh C, Aittomäki K, Hazekamp J, Nygren KG, Selbing A, Loft A. Children born after cryopreservation of embryos or oocytes: a systematic review of outcome data. Hum Reprod. 2009 Sep;24(9):2158-72.
  • 24. Nayak SR, Wakim AN. Random-start gonadotropin-releasing hormone (GnRH) antagonist-treated cycles with GnRH agonist trigger for fertility preservation. Fertil Steril. 2011 Jul; 96(1):e51-4.
  • 25. von Wolff M, Thaler CJ, Frambach T, Zeeb C, Lawrenz B, Popovici RM, Strowitzki T. Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril 2009; 92: 1360-1365.
  • 26. The Practice Committee of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. 2012. Mature oocyte cryopreservation: a guideline. Fertil Steril 2012.
  • 27. Cobo A, Diaz C. Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril 2011; 96: 277–85.
  • 28. Donnez J, Dolmans MM. Fertility preservation in women. Nat Rev Endocrinol. 2013 Dec; 9(12):735-49.
  • 29. Noyes N, Porcu E, Borini A. Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. Reprod Biomed Online. 2009 Jun; 18(6):769-76.
  • 30. Rosendahl M, Schmidt KT, Ernst E, Rasmussen PE, Loft A, Byskov AG, Andersen AN, Andersen CY. Cryopreservation of ovarian tissue for a decade in Denmark: a view of the technique. Reprod BioMed Online (2011) 22, 162– 171.
  • 31. Dolmans MM, Jadoul P, Gilliaux S, Amorim CA, Luyckx V, Squifflet J, Donnez J, Van Langendonckt A. A review of 15 years of ovarian tissue bank activities. J Assist Reprod Genet. 2013 Mar; 30(3):305-14.
  • 32. Schmidt KT, Ernst E, Greve T, Andersen CY.Transplantation of Frozen Thawed Ovarian Tissue – State of the Art. J. Reproduktionsmed. Endokrinol 2013; 10 (Sonderheft 1), 55-58.
  • 33. Donnez J, Dolmans MM, Pellicer A, Diaz-Garcia C, Sanchez Serrano M, Schmidt KT, Ernst E, Luyckx V, Andersen CY. Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertil Steril. 2013 May; 99(6):1503-13.
  • 34. Dolmans MM, Jadoul P, Gilliaux S, Amorim CA, Luyckx V, Squifflet J, Donnez J, Van Langendonckt A. A review of 15 years of ovarian tissue bank activities. J Assist Reprod Genet. 2013 Mar; 30(3):305-14.
  • 35. Donnez J, Dolmans MM. Fertility preservation in women. Nat Rev Endocrinol. 2013 Dec; 9(12):735-49.
  • 36. Stern CJ, Gook D, Hale LG, Agresta F, Oldham J, Rozen G, Jobling T. First reported clinical pregnancy following heterotopic grafting of cryopreserved ovarian tissue in a woman after a bilateral oophorectomy. Hum Reprod. 2013 Nov;28(11):2996-9.
  • 37. Andersen CY, Silber SJ, Bergholdt SH, Jorgensen JS, Ernst E. Long-term duration of function of ovarian tissue transplants: case reports. Reprod Biomed Online.
  • 38. Dolmans MM, Luyckx V, Donnez J, Andersen CY, Greve T. Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue. Fertil Steril. 2013 May; 99(6):1514-22.
  • 39. Dolmans MM, Jadoul P, Gilliaux S, Amorim CA, Luyckx V, Squifflet J, Donnez J, Van Langendonckt A. A review of 15 years of ovarian tissue bank activities. J Assist Reprod Genet. 2013 Mar; 30(3):305-14.
  • 40. Donnez J, Dolmans MM. Fertility preservation in women. Nat Rev Endocrinol. 2013 Dec; 9(12):735-49.
  • 41. Rosendahl, M., Andersen, C.Y., Ernst, E., et al. Ovarian function after removal of an entire ovary for cryopreservation of pieces of cortex prior to gonadotoxic treatment: a follow-up study. Hum Reprod 2008. 23, 2475–2483.
  • 42. Prasath EB, Chan MLH,Wong WHW, Lim CJW, Tharmalingam MD, Hendricks M, Loh, Chia WN. First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient. Hum. Reprod. Advance Access published December 9, 2013.
  • 43. Ernst E, Kjærsgaard M, Birkebæk NH, Clausen N, Andersen CY. Case report: stimulation of puberty in a girl with chemo- and radiation therapy induced ovarian failure by transplantation of a small part of her frozen/thawed ovarian tissue. Eur J Cancer. 2013 Mar; 49(4):911-4.
  • 44. Poirot C, Abirached F, Prades M, Coussieu C, Bernaudin F, Piver P. Induction of puberty by autograft of cryopreserved ovarian tissue. Lancet 2012; 379: 588.
  • 45. UpToDate®. Overview of fertility and pregnancy in cancer survivors. Literature review current through: Oct 2013. Topic last updated: Jul 29, 2013. Acessível em http://www.uptodate.com/contents/overview-of-fertility-and-pregnancy-in-cancer-survivors.

 

 

Última atualização: Fevereiro de 2014.

Informação elaborada com o apoio da

LPCC